144 related articles for article (PubMed ID: 37300767)
21. A novel serum-free monolayer culture for orderly hematopoietic differentiation of human pluripotent cells via mesodermal progenitors.
Niwa A; Heike T; Umeda K; Oshima K; Kato I; Sakai H; Suemori H; Nakahata T; Saito MK
PLoS One; 2011; 6(7):e22261. PubMed ID: 21818303
[TBL] [Abstract][Full Text] [Related]
22. Donor Dependent Variations in Hematopoietic Differentiation among Embryonic and Induced Pluripotent Stem Cell Lines.
Féraud O; Valogne Y; Melkus MW; Zhang Y; Oudrhiri N; Haddad R; Daury A; Rocher C; Larbi A; Duquesnoy P; Divers D; Gobbo E; Brunet de la Grange P; Louache F; Bennaceur-Griscelli A; Mitjavila-Garcia MT
PLoS One; 2016; 11(3):e0149291. PubMed ID: 26938212
[TBL] [Abstract][Full Text] [Related]
23. Reprogrammed cells for disease modeling and regenerative medicine.
Cherry AB; Daley GQ
Annu Rev Med; 2013; 64():277-90. PubMed ID: 23327523
[TBL] [Abstract][Full Text] [Related]
24. Directed differentiation of hematopoietic precursors and functional osteoclasts from human ES and iPS cells.
Grigoriadis AE; Kennedy M; Bozec A; Brunton F; Stenbeck G; Park IH; Wagner EF; Keller GM
Blood; 2010 Apr; 115(14):2769-76. PubMed ID: 20065292
[TBL] [Abstract][Full Text] [Related]
25. [After iPS, welcome to STAPs, a new reprogramming method].
Coulombel L
Med Sci (Paris); 2014 Feb; 30(2):214-7. PubMed ID: 24572124
[No Abstract] [Full Text] [Related]
26. Endogenous, very small embryonic-like stem cells: critical review, therapeutic potential and a look ahead.
Bhartiya D; Shaikh A; Anand S; Patel H; Kapoor S; Sriraman K; Parte S; Unni S
Hum Reprod Update; 2016 Dec; 23(1):41-76. PubMed ID: 27614362
[TBL] [Abstract][Full Text] [Related]
27. In vitro erythrocyte production using human-induced pluripotent stem cells: determining the best hematopoietic stem cell sources.
Cho YK; Kim HK; Kwon SS; Jeon SH; Cheong JW; Nam KT; Kim HS; Kim S; Kim HO
Stem Cell Res Ther; 2023 Apr; 14(1):106. PubMed ID: 37101221
[TBL] [Abstract][Full Text] [Related]
28. [Current status of differentiation studies from pluripotent stem cells (ES/iPS cells) to hematopoietic cells].
Tani K
Nihon Rinsho; 2015 Jun; 73 Suppl 5():147-52. PubMed ID: 30457763
[No Abstract] [Full Text] [Related]
29. Efficient conversion of human induced pluripotent stem cells into microglia by defined transcription factors.
Chen SW; Hung YS; Fuh JL; Chen NJ; Chu YS; Chen SC; Fann MJ; Wong YH
Stem Cell Reports; 2021 May; 16(5):1363-1380. PubMed ID: 33836143
[TBL] [Abstract][Full Text] [Related]
30. Haematopoietic developmental potential of human pluripotent stem cell lines.
Tesařová L; Simara P; Stejskal S; Koutná I
Folia Biol (Praha); 2014; 60 Suppl 1():90-4. PubMed ID: 25369348
[TBL] [Abstract][Full Text] [Related]
31. Orderly hematopoietic development of induced pluripotent stem cells via Flk-1(+) hemoangiogenic progenitors.
Niwa A; Umeda K; Chang H; Saito M; Okita K; Takahashi K; Nakagawa M; Yamanaka S; Nakahata T; Heike T
J Cell Physiol; 2009 Nov; 221(2):367-77. PubMed ID: 19562687
[TBL] [Abstract][Full Text] [Related]
32. Efficient Generation of β-Globin-Expressing Erythroid Cells Using Stromal Cell-Derived Induced Pluripotent Stem Cells from Patients with Sickle Cell Disease.
Uchida N; Haro-Mora JJ; Fujita A; Lee DY; Winkler T; Hsieh MM; Tisdale JF
Stem Cells; 2017 Mar; 35(3):586-596. PubMed ID: 27739611
[TBL] [Abstract][Full Text] [Related]
33. Hematopoietic and endothelial differentiation of human induced pluripotent stem cells.
Choi KD; Yu J; Smuga-Otto K; Salvagiotto G; Rehrauer W; Vodyanik M; Thomson J; Slukvin I
Stem Cells; 2009 Mar; 27(3):559-67. PubMed ID: 19259936
[TBL] [Abstract][Full Text] [Related]
34. Generation and characterization of human induced pluripotent stem cells.
Ohnuki M; Takahashi K; Yamanaka S
Curr Protoc Stem Cell Biol; 2009 Jun; Chapter 4():Unit 4A.2. PubMed ID: 19536759
[TBL] [Abstract][Full Text] [Related]
35. Efficient and simultaneous generation of hematopoietic and vascular progenitors from human induced pluripotent stem cells.
Park TS; Zimmerlin L; Zambidis ET
Cytometry A; 2013 Jan; 83(1):114-26. PubMed ID: 22736485
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of Lnk in mouse induced pluripotent stem cells promotes hematopoietic cell generation.
Tashiro K; Omori M; Kawabata K; Hirata N; Yamaguchi T; Sakurai F; Takaki S; Mizuguchi H
Stem Cells Dev; 2012 Dec; 21(18):3381-90. PubMed ID: 22738147
[TBL] [Abstract][Full Text] [Related]
37. ID1 and ID3 represent conserved negative regulators of human embryonic and induced pluripotent stem cell hematopoiesis.
Hong SH; Lee JH; Lee JB; Ji J; Bhatia M
J Cell Sci; 2011 May; 124(Pt 9):1445-52. PubMed ID: 21486943
[TBL] [Abstract][Full Text] [Related]
38. iPS cells: a source of cardiac regeneration.
Yoshida Y; Yamanaka S
J Mol Cell Cardiol; 2011 Feb; 50(2):327-32. PubMed ID: 21040726
[TBL] [Abstract][Full Text] [Related]
39. Comparison of efficiency of terminal differentiation of oligodendrocytes from induced pluripotent stem cells versus embryonic stem cells in vitro.
Tokumoto Y; Ogawa S; Nagamune T; Miyake J
J Biosci Bioeng; 2010 Jun; 109(6):622-8. PubMed ID: 20471604
[TBL] [Abstract][Full Text] [Related]
40. A defined, feeder-free, serum-free system to generate in vitro hematopoietic progenitors and differentiated blood cells from hESCs and hiPSCs.
Salvagiotto G; Burton S; Daigh CA; Rajesh D; Slukvin II; Seay NJ
PLoS One; 2011 Mar; 6(3):e17829. PubMed ID: 21445267
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
